SFX by Ex Libris Inc.

Title:	Multidrug evolutionary strategies to reverse antibiotic resistance
Source:	Science [0036-8075] Baym, M yr:2016

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	George, A.. "March of the superbugs." New Scientist 178.2404 (2003): 1-.
description	2.	Roberts, Marilyn C., C. "Antibiotic resistance mechanisms in bacteria of oral and upper respiratory origin." International journal of antimicrobial agents 9.4 (1998): 255-267.
description	3.	Li, Qing, Q. "NB2001, a novel antibacterial agent with broad-spectrum activity and enhanced potency against beta-lactamase-producing strains." Antimicrobial agents and chemotherapy 46.5 (2002): 1262-1268.
description	4.	Smith, A. "Combating bacteria and drug resistance by inhibiting mechanisms of persistence and adaptation." Nature chemical biology 3.9 (2007): 549-556.
description	5.	Cunha, B A A. "Effective antibiotic-resistance control strategies." Lancet, The 357.9265 (2001): 1307-8.
description	6.	Walsh, C. "Molecular mechanisms that confer antibacterial drug resistance." Nature 406.6797 (2000): 775-81.
description	7.	Hung, E. "Targeting virulence: a new paradigm for antimicrobial therapy." Nature chemical biology 3.9 (2007): 541-548.
description	8.	Cunha, B A A. "Antibiotic resistance. Control strategies." Critical care clinics 14.2 (1998): 309-27.
description	9.	Weigel, Linda M M. "Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus." Science 302.5650 (2003): 1569-71.
description	10.	Xu, Justin e. "The expression of antibiotic resistance genes in antibiotic-producing bacteria." Molecular microbiology 93.3 (2014): 391-402.
description	11.	Stachyra, T. "In vitro activity of the β-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases." The Journal of Antimicrobial Chemotherapy 64.2 (2009): 326-329.
description	12.	Hoffmann, A. "Metabolically deficient methicillin-resistant Staphylococcus aureus as cause of chronic post-thoracotomy sternal wound infection." European journal of clinical microbiology & infectious diseases 23.5 (2004): 419-21.
description	13.	Woodford, N. "Infections caused by Gram-positive bacteria: a review of the global challenge." The Journal of infection 59.1 (2009): 4-16.
description	14.	M, F.. "Superbugs in waiting: Some cautionary tales." Science 255.5040 (1992): 29-27.
description	15.	Yoneyama, H.. "Antibiotic resistance in bacteria and its future for novel antibiotic development." Bioscience, biotechnology, and biochemistry 70.5 (2006): 1060-1075.
description	16.	Gray, J. "Too many 'superbugs'." Nursing standard 17.18 (2003): 3-3.
description	17.	Gibbons, S. "Plants as a source of bacterial resistance modulators and anti-infective agents." Phytochemistry reviews 4.1 (2005): 63-78.
description	18.	Hososaka, Y.. "Nosocomial infection of beta-lactam antibiotic-induced vancomycin-resistant Staphylococcus aureus (BIVR)." Journal of infection and chemotherapy 12.4 (2006): 181-184.
description	19.	Zorrilla, E. "[Evaluation of a computer predictive model to stratify risk and site of care in community acquired pneumonia]." Anales de medicina interna 24.3 (2007): 120-4.
description	20.	Richman, P. "Aerosolized antibiotics and ventilator associated tracheobronchitis in the intensive care unit." Critical care medicine 36.7 (2008): 2008-13.